• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匈牙利单中心研究中前四波疫情期间新冠病毒疾病严重程度和死亡率的比较,特别关注重症监护病房中的危重症患者。

Comparison of COVID-19 Severity and Mortality Rates in the First Four Epidemic Waves in Hungary in a Single-Center Study with Special Regard to Critically Ill Patients in an Intensive Care Unit.

作者信息

Nagy Éva, Golopencza Péter, Barcs István, Ludwig Endre

机构信息

Schools of PhD Studies, Semmelweis University, 1085 Budapest, Hungary.

Bajcsy-Zsilinszky Hospital and Outpatient Clinic, 1106 Budapest, Hungary.

出版信息

Trop Med Infect Dis. 2023 Mar 1;8(3):153. doi: 10.3390/tropicalmed8030153.

DOI:10.3390/tropicalmed8030153
PMID:36977154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10054791/
Abstract

Different variants of coronavirus 2 (SARS-CoV-2), a virus responsible for severe acute respiratory syndrome, caused several epidemic surges in Hungary. The severity of these surges varied due to the different virulences of the variants. In a single-center, retrospective, observational study, we aimed to assess and compare morbidities and mortality rates across the epidemic waves I to IV with special regard to hospitalized, critically ill patients. A significant difference was found between the surges with regard to morbidity ( < 0.001) and ICU mortality ( = 0.002), while in-hospital mortality rates ( = 0.503) did not differ significantly. Patients under invasive ventilation had a higher incidence of bloodstream infection (aOR: 8.91 [4.43-17.95] < 0.001), which significantly increased mortality (OR: 3.32 [2.01-5.48]; < 0.001). Our results suggest that Waves III and IV, caused by the alpha (B.1.1.7) and delta (B.1.617.2) variants, respectively, were more severe in terms of morbidity. The incidence of bloodstream infection was high in critically ill patients. Our results suggest that clinicians should be aware of the risk of bloodstream infection in critically ill ICU patients, especially when invasive ventilation is used.

摘要

导致严重急性呼吸综合征的冠状病毒2(SARS-CoV-2)的不同变体在匈牙利引发了多次疫情高峰。由于变体的毒力不同,这些高峰的严重程度也有所不同。在一项单中心、回顾性、观察性研究中,我们旨在评估和比较第一波至第四波疫情期间的发病率和死亡率,特别关注住院的重症患者。在发病率(<0.001)和重症监护病房死亡率(=0.002)方面,各波疫情之间存在显著差异,而住院死亡率(=0.503)没有显著差异。接受有创通气的患者发生血流感染的发生率更高(调整后比值比:8.91[4.43 - 17.95],<0.001),这显著增加了死亡率(比值比:3.32[2.01 - 5.48];<0.001)。我们的结果表明,分别由α(B.1.1.7)和δ(B.1.617.2)变体引起的第三波和第四波疫情在发病率方面更为严重。重症患者中血流感染的发生率很高。我们的结果表明,临床医生应意识到重症监护病房重症患者发生血流感染的风险,尤其是在使用有创通气时。

相似文献

1
Comparison of COVID-19 Severity and Mortality Rates in the First Four Epidemic Waves in Hungary in a Single-Center Study with Special Regard to Critically Ill Patients in an Intensive Care Unit.匈牙利单中心研究中前四波疫情期间新冠病毒疾病严重程度和死亡率的比较,特别关注重症监护病房中的危重症患者。
Trop Med Infect Dis. 2023 Mar 1;8(3):153. doi: 10.3390/tropicalmed8030153.
2
Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.COVID-19 危重症患者的继发感染:一项回顾性单中心评估。
BMC Infect Dis. 2022 Mar 2;22(1):207. doi: 10.1186/s12879-022-07192-x.
3
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
4
Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19-A Retrospective Study.新冠重症患者重症监护病房心脏骤停的特征与危险因素——一项回顾性研究
J Clin Med. 2021 May 19;10(10):2195. doi: 10.3390/jcm10102195.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves.连续四波新冠疫情期间重症监护病房的血流感染
Antibiotics (Basel). 2023 Sep 14;12(9):1448. doi: 10.3390/antibiotics12091448.
7
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.西班牙感染新型冠状病毒肺炎(SARS-CoV-2)的危重症患者的特征、临床病程及与重症监护病房(ICU)死亡率相关的因素:一项前瞻性队列多中心研究
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437. doi: 10.1016/j.redar.2020.07.003. Epub 2020 Jul 13.
8
Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza.比较 COVID-19 与流感住院危重症患者的临床特征和结局。
Ann Am Thorac Soc. 2021 Apr;18(4):632-640. doi: 10.1513/AnnalsATS.202007-805OC.
9
Vitamin D deficiency is Associated with Increased Risk of Delirium and Mortality among Critically Ill, Elderly Covid-19 Patients.维生素 D 缺乏与重症、老年 COVID-19 患者发生谵妄和死亡风险增加相关。
Complement Ther Med. 2022 Nov;70:102855. doi: 10.1016/j.ctim.2022.102855. Epub 2022 Jul 19.
10
Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China.中国武汉 COVID-19 重症或危重症 ICU 患者的呼吸支持。
Curr Med Sci. 2020 Aug;40(4):636-641. doi: 10.1007/s11596-020-2227-8. Epub 2020 Aug 29.

引用本文的文献

1
COVID-19 mortality prediction in Hungarian ICU settings implementing random forest algorithm.在实施随机森林算法的匈牙利 ICU 环境中预测 COVID-19 死亡率。
Sci Rep. 2024 May 24;14(1):11941. doi: 10.1038/s41598-024-62791-9.
2
Asymptomatic and Mild SARS-CoV-2 Infections in a Hungarian Outpatient Cohort in the First Year of the COVID-19 Pandemic.COVID-19大流行第一年匈牙利门诊队列中的无症状和轻度SARS-CoV-2感染
Trop Med Infect Dis. 2023 Mar 29;8(4):204. doi: 10.3390/tropicalmed8040204.

本文引用的文献

1
The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients-A Retrospective Study in a Hungarian Hospital.合并症和肥胖对住院 COVID-19 患者严重程度和结局的影响——匈牙利医院的回顾性研究。
Int J Environ Res Public Health. 2023 Jan 12;20(2):1372. doi: 10.3390/ijerph20021372.
2
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia.抗生素治疗的 COVID-19 患者肠道微生物组失调与微生物易位和菌血症有关。
Nat Commun. 2022 Nov 1;13(1):5926. doi: 10.1038/s41467-022-33395-6.
3
[Thromboembolic complications in COVID-19 patients].
[新型冠状病毒肺炎患者的血栓栓塞并发症]
Orv Hetil. 2021 Oct 24;162(43):1710-1716. doi: 10.1556/650.2021.32342.
4
Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study.爱尔兰新冠肺炎患者的基础疾病以及住院、入住重症监护病房和死亡风险:一项全国性监测研究。
Lancet Reg Health Eur. 2021 Jun;5:100097. doi: 10.1016/j.lanepe.2021.100097. Epub 2021 Apr 15.
5
Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies.COVID-19 患者入住重症监护病房的死亡率:一项更新的观察性研究系统评价和荟萃分析。
Anaesthesia. 2021 Apr;76(4):537-548. doi: 10.1111/anae.15425. Epub 2021 Feb 1.
6
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.COVID-19 增加了 ICU 获得性血流感染的风险:来自多中心 OUTCOMEREA 网络的病例队列研究。
Intensive Care Med. 2021 Feb;47(2):180-187. doi: 10.1007/s00134-021-06346-w. Epub 2021 Jan 27.
7
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect".COVID-19 患者重症监护中细菌和真菌感染性血流感染的发生率:令人震惊的“附带效应”。
J Glob Antimicrob Resist. 2020 Dec;23:290-291. doi: 10.1016/j.jgar.2020.10.004. Epub 2020 Oct 29.
8
Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study.COVID-19 患者入住意大利 ICU 期间肠球菌血流感染的意外高发:一项观察性研究。
Crit Care Med. 2021 Jan 1;49(1):e31-e40. doi: 10.1097/CCM.0000000000004748.
9
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
10
Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis.托珠单抗治疗 COVID-19 的疗效:系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1620-1630. doi: 10.1002/jmv.26509. Epub 2020 Sep 28.